Understanding the Role of Targets and Pathways in the Treatment of Non–Small Cell Lung Cancer
Although this activity has expired, you may still view the supplement content. However, you will not be able to obtain CE credit.
A continuing education article for physicians, PAs, doctors of nursing practice, nurse practitioners, advanced practice nurses including clinical nurse specialists, and other advanced degree nurses.
Faculty
Lisa Cordes, PharmD, BCACP, BCOP, National Institutes of Health
Sandra Cuellar, PharmD, BCOP, University of Illinois Hospital and Health Sciences System—Pharmacy Practice
Marianne Davies, DNP, MSN, CNS, ACNP, AOCNP®, Yale University School of Nursing
Beth Eaby-Sandy, MSN, CRNP, OCN®, Abramson Cancer Center, Hospital of the University of Pennsylvania
Clell Hasenbank, PharmD, Providence St Mary Regional Cancer Center
Karen Oishi, MSN, APRN, AGPCNP-BC, OCN®, The University of Texas MD Anderson Cancer Center
Melinda Oliver, BA, BSN, RN, MPAP, The University of Texas MD Anderson Cancer Center
Samantha Schmidt, PharmD, Lexington Medical Center
Helen Shih, MSN, MPH, University of California, San Francisco Department of Thoracic Oncology
Grashma Vadakkel, PharmD(c), University of South Florida College of Pharmacy
Elizabeth S. Waxman, RN, MSN, AOCN®, ANP-BC, The University of Texas MD Anderson Cancer Center
This supplement is supported by educational grants from the following companies: Genentech and Merck Sharp & Dohme Corp.
Editorial
Letter From the Guest Editors
Read MoreEditorial
Take a Deep Breath: More Treatment Options for Non–Small Cell Lung Cancer
Lisa Cordes, PharmD, BCACP, BCOP, and Elizabeth S. Waxman, RN, MSN, AOCN®, ANP-BCRead MoreReview Article
Diagnosis of Lung Cancer
Marianne Davies, DNP, MSN, CNS, ACNP, AOCNP®, and Helen Shih, MSN, MPHRead MoreReview Article
Fundamentals of Lung Cancer Staging
Marianne Davies, DNP, MSN, CNS, ACNP, AOCNP®Read MoreReview Article
Predictive and Prognostic Biomarkers and Related Therapies in Non–Small Cell Lung Cancer
Samantha Schmidt, PharmD, and Grashma Vadakkel, PharmD(c)Read MoreReview Article
Supportive Care and Management of Treatment-Emergent Adverse Events With Targeted Therapy in Non–Small Cell Lung Cancer
Clell Hasenbank, PharmDRead MoreReview Article
Emerging Biomarkers in Non–Small Cell Lung Cancer
Melinda Oliver, BA, BSN, RN, MPAPRead MoreReview Article
Immunotherapy Mechanisms of Action in Non–Small Cell Lung Cancer
Beth Eaby-Sandy, MSN, CRNP, OCN®Read MoreReview Article
Unleashing the Immune System With Checkpoint Inhibitors in Non–Small Cell Lung Cancer: Clinical Review of Adverse Events
Sandra Cuellar, PharmD, BCOPRead MoreReview Article
Emerging Therapies in Non–Small Cell Lung Cancer: Clinical Trials With Novel Agents
Karen Oishi, MSN, APRN, AGPCNP-BC, OCN®Read MoreTools and Technology
Resources for Patients With Non–Small Cell Lung Cancer and Their Caregivers and Providers
Elizabeth S. Waxman, RN, MSN, AOCN®, ANP-BCRead MoreAppendix
Appendix
Lisa Cordes, PharmD, BCACP, BCOPRead MoreEditorial
Priming the Pump Task Force
Read More